SEC Form 4 · accession 0000930413-19-000104

ENZO BIOCHEM INC · ENZ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jan 14, 2019

Accepted (ET)

Jan 18, 2019 · 4:30 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000316253

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jan 14, 2019	M	9,184	$2.70	A	65,787	D
Common Stock^F2	holding	—	—		—	523,457	I	See Footnotes

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock option (to acquire common stock)^F1	$2.70	Jan 14, 2019	M	64,286	D	—	Jan 17, 2019	Common Stock	64,286	175,346	D

F1Represents an exercise of options to acquire 64,286 shares, which, after the company withheld the exercise price for such options, resulted in a delivery of 9,184 shares of common stock to the reporting person.
F2Includes (i) 33,139 shares owned by Laya Perlysky (Mr. Perlysky's wife) of which Mr. Perlysky disclaims beneficial ownership, (ii) 109,237 shares owned directly by RSD 2012 GRAT, of which Mr. Perlysky is the trustee of which Mr. Perlysky disclaims beneficial ownership, (iii) 45,000 shares owned by Sky Ventures LLC, of which Mr. Perlysky is the manager and of which Dov Perlysky disclaims beneficial ownership, (iv) 325,875 shares owned by Kinder Investments LLP, an entity of which Dov Perlysky is the Managing Member of the General Partner and of which Dov Perlysky disclaims beneficial ownership, (v) 6,981 shares owned by Krovim LLC, an entity of which Dov Perlysky is the Managing Member of the General Partner, and children of Dov Perlysky own a 27.54% interest, and of which Dov Perlysky disclaims beneficial ownership and (vi) 3,225 shares owned by MidAtlantic Capital Lending LLC, an entity of which Dov Perlysky owns 1% and of which Dov Perlysky disclaims beneficial ownership.